The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for InVivoScribe Technologies sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. InVivoScribe also provides general purpose reagents such as PCR and cDNA reagents, gel detection reagents and ABI fluorescence detection reagents. The company offers PCR-based gene rearrangement, chromosome translocation, and gene mutation research use only testing reagents and controls. It provides its in vitro diagnostic cGMP products for hematology-oncology, RUO assays, analyte specific reagents, and DNA and RNA controls. The company operates through research laboratories located in Japan. InVivoScribe is headquartered in San Diego, California, the US. Key subsidiaries of InVivoScribe Technologies include Genection, LabPMM, Laboratory for Personalized Molecular Medicine and InVivoScribe Technologies.
The key metrics of InVivoScribe Technologies related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As InVivoScribe Technologies is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as InVivoScribe Technologies.
For a detailed understanding of the performance of InVivoScribe Technologies, buy the report here.